LAVA Therapeutics NV (LAVA Therapeutics NV) Price-to-Tangible-Book : 1.49 (As of Apr. 30, 2024)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Price-to-Tangible-Book?

As of today (2024-04-30), LAVA Therapeutics NV's share price is $2.90. LAVA Therapeutics NV's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $1.95. Hence, LAVA Therapeutics NV's Price to Tangible Book Ratio of today is 1.49.

The historical rank and industry rank for LAVA Therapeutics NV's Price-to-Tangible-Book or its related term are showing as below:

LVTX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.81 Med: 1.07 Max: 1.53
Current: 1.49

During the past 5 years, LAVA Therapeutics NV's highest Price to Tangible Book Ratio was 1.53. The lowest was 0.81. And the median was 1.07.

LVTX's Price-to-Tangible-Book is ranked better than
72.62% of 1220 companies
in the Biotechnology industry
Industry Median: 2.69 vs LVTX: 1.49

A closely related ratio is called PB Ratio. As of today, LAVA Therapeutics NV's share price is $2.90. LAVA Therapeutics NV's Book Value per Sharefor the quarter that ended in Dec. 2023 was $1.95. Hence, LAVA Therapeutics NV's P/B Ratio of today is 1.49.

LAVA Therapeutics NV Price-to-Tangible-Book Historical Data

The historical data trend for LAVA Therapeutics NV's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Price-to-Tangible-Book Chart

LAVA Therapeutics NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

1.20

1.07

0.81

LAVA Therapeutics NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial												1.07	0.58	0.84	0.71	0.81

Competitive Comparison of LAVA Therapeutics NV's Price-to-Tangible-Book

For the Biotechnology subindustry, LAVA Therapeutics NV's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LAVA Therapeutics NV's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LAVA Therapeutics NV's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where LAVA Therapeutics NV's Price-to-Tangible-Book falls into.

LAVA Therapeutics NV Price-to-Tangible-Book Calculation

LAVA Therapeutics NV's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	2.90	/	1.947
	=	1.49

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

LAVA Therapeutics NV Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

4PKB:Germany

Address

Yalelaan 62, Utrecht, UT, NLD, 3584 CM

Website

https://www.lavatherapeutics.com

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.